4.6 Article

Survival Benefit-Based Deceased-Donor Liver Allocation

Journal

AMERICAN JOURNAL OF TRANSPLANTATION
Volume 9, Issue 4, Pages 970-981

Publisher

WILEY
DOI: 10.1111/j.1600-6143.2009.02571.x

Keywords

Albumin; bilirubin; creatinine; Model for End-stage Liver Disease (MELD); organ allocation; Organ Procurement and Transplantation Network (OPTN); Scientific Registry of Transplant Recipients (SRTR); waiting list

Funding

  1. Health Resources and Services Administration (HRSA), US Department of Health and Human Services [234-2005-37009C]
  2. National Institutes of Health [R01 DK-70869]
  3. National Center for Research Resources (NCRR) [KL2 RR024130]
  4. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK076565]
  5. Agency for Healthcare Research and Quality (AHRQ)
  6. NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024130] Funding Source: NIH RePORTER
  7. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070869, K08DK076565] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Currently, patients awaiting deceased-donor liver transplantation are prioritized by medical urgency. Specifically, wait-listed chronic liver failure patients are sequenced in decreasing order of Model for End-stage Liver Disease (MELD) score. To maximize lifetime gained through liver transplantation, posttransplant survival should be considered in prioritizing liver waiting list candidates. We evaluate a survival benefit based system for allocating deceased-donor livers to chronic liver failure patients. Under the proposed system, at the time of offer, the transplant survival benefit score would be computed for each patient active on the waiting list. The proposed score is based on the difference in 5-year mean lifetime (with vs. without a liver transplant) and accounts for patient and donor characteristics. The rank correlation between benefit score and MELD score is 0.67. There is great overlap in the distribution of benefit scores across MELD categories, since waiting list mortality is significantly affected by several factors. Simulation results indicate that over 2000 life-years would be saved per year if benefit-based allocation was implemented. The shortage of donor livers increases the need to maximize the life-saving capacity of procured livers. Allocation of deceased-donor livers to chronic liver failure patients would be improved by prioritizing patients by transplant survival benefit.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available